Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.
暂无分享,去创建一个
Peter Tomasulo | Hany Kamel | Sally Caglioti | Michael P Busch | H. Kamel | P. Tomasulo | S. Kleinman | V. Shyamala | M. Busch | E. F. Robertson | L. Tobler | J. Linnen | Steven H Kleinman | Venkatakrishna Shyamala | Leslie H Tobler | Eugene F Robertson | Joan D McAuley | Jeffrey M Linnen | S. Caglioti | J. McAuley | M. Busch
[1] S. Glynn,et al. A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors , 2005, Transfusion.
[2] J. Epstein. Insights on donor screening for West Nile virus , 2005, Transfusion.
[3] S. Glynn,et al. The 2003 West Nile virus United States epidemic: the America's Blood Centers experience , 2005, Transfusion.
[4] P. Tomasulo,et al. Triggers for switching from minipool testing by nucleic acid technology to individual‐donation nucleic acid testing for West Nile virus: Analysis of 2003 data to inform 2004 decision making , 2004, Transfusion.
[5] C. Southam,et al. Induced virus infections in man by the Egypt isolates of West Nile virus. , 1954, The American journal of tropical medicine and hygiene.
[6] R. Lanciotti,et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. , 2003, The New England journal of medicine.
[7] Michael Engle,et al. A Critical Role for Induced IgM in the Protection against West Nile Virus Infection , 2003, The Journal of experimental medicine.
[8] Sally Caglioti,et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. , 2004, The New England journal of medicine.
[9] J. Wong,et al. Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States , 2004, Vox sanguinis.
[10] L. Mimms,et al. Highly Sensitive Multiplex Assay for Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA , 2002, Journal of Clinical Microbiology.
[11] S. Kleinman,et al. Transfusion transmission of West Nile virus: a merging of historical and contemporary perspectives , 2003, Transfusion.
[12] M. Drebot,et al. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003 , 2005, Transfusion.
[13] S. Krugman,et al. Infectious hepatitis: detection of virus during the incubation period and in clinically inapparent infection. , 1959, The New England journal of medicine.
[14] A. Barrett,et al. Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection. , 2004, The Journal of infectious diseases.
[15] R. Dodd. Emerging infections, transfusion safety, and epidemiology. , 2003, The New England journal of medicine.
[16] W. Hogrefe,et al. Detection of West Nile Virus (WNV)-Specific Immunoglobulin M in a Reference Laboratory Setting during the 2002 WNV Season in the United States , 2003, Clinical Diagnostic Laboratory Immunology.
[17] B. Turnbull. The Empirical Distribution Function with Arbitrarily Grouped, Censored, and Truncated Data , 1976 .